A new predictor of in-stent restenosis in patients undergoing elective percutaneous coronary İntervention: triglyceride glucose İndex

Objective: This study aimed to investigate whether triglyceride glucose (TyG) index predicts the development of in-stent restenosis (ISR) in patients undergoing percutaneous coronary intervention (PCI) for de novo lesions. Materials and Methods: This was a prospective case controlled study and inclu...

Full description

Bibliographic Details
Main Authors: Muhsin Kalyoncuoglu, Alev Arat Ozkan, Aysem Kaya, Yasin Yuksel, Nafi Dogan, Aziz Tevfik Gurmen
Format: Article
Language:English
Published: Galenos Publishing House 2021-01-01
Series:International Journal of the Cardiovascular Academy
Subjects:
Online Access:http://www.ijcva.com/article.asp?issn=2405-8181;year=2021;volume=7;issue=2;spage=50;epage=54;aulast=Kalyoncuoglu
_version_ 1827833738132717568
author Muhsin Kalyoncuoglu
Alev Arat Ozkan
Aysem Kaya
Yasin Yuksel
Nafi Dogan
Aziz Tevfik Gurmen
author_facet Muhsin Kalyoncuoglu
Alev Arat Ozkan
Aysem Kaya
Yasin Yuksel
Nafi Dogan
Aziz Tevfik Gurmen
author_sort Muhsin Kalyoncuoglu
collection DOAJ
description Objective: This study aimed to investigate whether triglyceride glucose (TyG) index predicts the development of in-stent restenosis (ISR) in patients undergoing percutaneous coronary intervention (PCI) for de novo lesions. Materials and Methods: This was a prospective case controlled study and includes 124 patients with a mean age of 57 ± 9.1. Control coronary angiography was performed in all patients enrolled in the study 6–12 months after the PCI. Blood sample triglycerides (TGs) and blood glucose concentrations were collected after at least 8 h of fasting. The TyG index was calculated as follows: log (serum TGs [mg/dL] × plasma glucose [mg/dL]/2). The study cohort was divided into two groups as those with and without restenosis. Angiographically, stent restenosis, defined as the presence of ≥50% diameter narrowing either within the stent or within 5 mm proximally or distally to the stent margin. Results: The median follow-up time was 7.17 months (±2.01). Forty-eight patients (38.7%) had restenosis. Patients with ISR had more diabetes (P < 0.01) and CAD (P = 0.03). These also had higher TyG index (P = 0.04) and less drug-eluting stent implantation (P = 0.04). Diabetes (odds ratio [OR]: 1.927, P = 0.03), stent type (OR: 0.342, P = 0.02), and TyG index (OR: 4.144, P = 0.01) significantly predicted ISR. The receiver operating characteristics curve analysis revealed a cutoff value of TyG index >4.71 predicts the development of ISR. Conclusion: A TyG above 4.71 was found a risk factor for ISR during 1-year follow-up period after index elective PCI.
first_indexed 2024-03-12T05:36:29Z
format Article
id doaj.art-76b0298973ff432c85c4a2040d5557c9
institution Directory Open Access Journal
issn 2405-8181
2405-819X
language English
last_indexed 2024-03-12T05:36:29Z
publishDate 2021-01-01
publisher Galenos Publishing House
record_format Article
series International Journal of the Cardiovascular Academy
spelling doaj.art-76b0298973ff432c85c4a2040d5557c92023-09-03T06:21:51ZengGalenos Publishing HouseInternational Journal of the Cardiovascular Academy2405-81812405-819X2021-01-0172505410.4103/ijca.ijca_15_21A new predictor of in-stent restenosis in patients undergoing elective percutaneous coronary İntervention: triglyceride glucose İndexMuhsin KalyoncuogluAlev Arat OzkanAysem KayaYasin YukselNafi DoganAziz Tevfik GurmenObjective: This study aimed to investigate whether triglyceride glucose (TyG) index predicts the development of in-stent restenosis (ISR) in patients undergoing percutaneous coronary intervention (PCI) for de novo lesions. Materials and Methods: This was a prospective case controlled study and includes 124 patients with a mean age of 57 ± 9.1. Control coronary angiography was performed in all patients enrolled in the study 6–12 months after the PCI. Blood sample triglycerides (TGs) and blood glucose concentrations were collected after at least 8 h of fasting. The TyG index was calculated as follows: log (serum TGs [mg/dL] × plasma glucose [mg/dL]/2). The study cohort was divided into two groups as those with and without restenosis. Angiographically, stent restenosis, defined as the presence of ≥50% diameter narrowing either within the stent or within 5 mm proximally or distally to the stent margin. Results: The median follow-up time was 7.17 months (±2.01). Forty-eight patients (38.7%) had restenosis. Patients with ISR had more diabetes (P < 0.01) and CAD (P = 0.03). These also had higher TyG index (P = 0.04) and less drug-eluting stent implantation (P = 0.04). Diabetes (odds ratio [OR]: 1.927, P = 0.03), stent type (OR: 0.342, P = 0.02), and TyG index (OR: 4.144, P = 0.01) significantly predicted ISR. The receiver operating characteristics curve analysis revealed a cutoff value of TyG index >4.71 predicts the development of ISR. Conclusion: A TyG above 4.71 was found a risk factor for ISR during 1-year follow-up period after index elective PCI.http://www.ijcva.com/article.asp?issn=2405-8181;year=2021;volume=7;issue=2;spage=50;epage=54;aulast=Kalyoncuogluglucose indexglucoserestenosistriglycerides
spellingShingle Muhsin Kalyoncuoglu
Alev Arat Ozkan
Aysem Kaya
Yasin Yuksel
Nafi Dogan
Aziz Tevfik Gurmen
A new predictor of in-stent restenosis in patients undergoing elective percutaneous coronary İntervention: triglyceride glucose İndex
International Journal of the Cardiovascular Academy
glucose index
glucose
restenosis
triglycerides
title A new predictor of in-stent restenosis in patients undergoing elective percutaneous coronary İntervention: triglyceride glucose İndex
title_full A new predictor of in-stent restenosis in patients undergoing elective percutaneous coronary İntervention: triglyceride glucose İndex
title_fullStr A new predictor of in-stent restenosis in patients undergoing elective percutaneous coronary İntervention: triglyceride glucose İndex
title_full_unstemmed A new predictor of in-stent restenosis in patients undergoing elective percutaneous coronary İntervention: triglyceride glucose İndex
title_short A new predictor of in-stent restenosis in patients undergoing elective percutaneous coronary İntervention: triglyceride glucose İndex
title_sort new predictor of in stent restenosis in patients undergoing elective percutaneous coronary intervention triglyceride glucose index
topic glucose index
glucose
restenosis
triglycerides
url http://www.ijcva.com/article.asp?issn=2405-8181;year=2021;volume=7;issue=2;spage=50;epage=54;aulast=Kalyoncuoglu
work_keys_str_mv AT muhsinkalyoncuoglu anewpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT alevaratozkan anewpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT aysemkaya anewpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT yasinyuksel anewpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT nafidogan anewpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT aziztevfikgurmen anewpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT muhsinkalyoncuoglu newpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT alevaratozkan newpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT aysemkaya newpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT yasinyuksel newpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT nafidogan newpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex
AT aziztevfikgurmen newpredictorofinstentrestenosisinpatientsundergoingelectivepercutaneouscoronaryinterventiontriglycerideglucoseindex